Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Annals of Hematology|May 6, 2004
Transplantation strategies in AML: AMLCG dataJ Kienast, M Stelljes, B Berning, et al.
British Journal of Haematology|February 26, 2000
Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cellsR Fenski, K Flesch, S Serve, et al.
Annals of Hematology|August 1, 1993
Comparison of 5 vs 10 micrograms/kg per day of GM-CSF following dose-intensified chemotherapy with cisplatin, etoposide, and ifosfamide in patients with advanced testicular cancerC Bokemeyer, H J Schmoll, B Metzner, et al.
Seminars in Oncology|December 1, 1994
The role of granulocyte-macrophage colony-stimulating factor in the treatment of germ cell tumors. German Testicular Cancer Study GroupC Bokemeyer, A Harstrick, U Rüther, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinomaA Harstrick, H J Schmoll, C Bokemeyer, et al.
Bone Marrow Transplantation|August 30, 2008
The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow TransplantationM Stelljes, A van Biezen, S Slavin, et al.
Mycoses|April 5, 2012
Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitalsC T Rieger, O A Cornely, T Hoppe-Tichy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 1999
Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapyM Mohr, E Hilgenfeld, T Fietz, et al.
Mycoses|May 11, 2011
Current issues in the clinical management of invasive candida infections--the AGIHO, DMykG, ÖGMM and PEG web-based survey and expert consensus conference 2009M Karthaus, M J G T Rüping, O A Cornely, et al.
Infection|June 29, 2006
A prospective, randomized multicenter trial of the empirical addition of antifungal therapy for febrile neutropenic cancer patients: results of the Paul Ehrlich Society for Chemotherapy (PEG) Multicenter Trial IIX Schiel, H Link, G Maschmeyer, et al.
Pageof 12